Answers are grounded in this paper and cite their sources.
Reveals conserved pathology-associated cell populations across species, suggesting the potential for cross-species analysis in biomedical research.
Summary Single-cell RNA sequencing (scRNA-seq) enables high-resolution profiling of cellular heterogeneity, but integrating data across species remains challenging due to technical variation and complex gene homology. We present TACMAN (transformer-based alignment of cross-species metapath aggregation network), a computational framework for cross-species scRNA-seq integration that combines a metapath-based heterogeneous graph neural network with an encoder-only transformer. TACMAN aligns conserved cell types across species under normal physiological conditions while preserving biological signals. We demonstrate its utility by integrating clinical human and mammalian model scRNA-seq data, revealing conserved cell subtypes in tumor, inflammatory, and infectious diseases. Notably, using our in-house single-cell transcriptomic atlas of an evolutionarily distant Caenorhabditis elegans germline tumor model, TACMAN identifies tumor-related cell populations conserved in human testicular germ cell tumor samples, enabling cross-species comparison under pathological conditions. TACMAN thus offers a powerful tool for comparative single-cell analysis, advancing translational research using animal models.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: